International Journal of Cosmetic Science , 31(5), 327-345.
At the same time, Glutone 1000 gains our recommendation as the better named-source product
Notably, the Phase I clinical data reveal that the most frequent treatment-related adverse events (TRAEs) were predominantly hematologic (e.g., neutropenia [86.8%], leukopenia [90.1%], thrombocytopenia [71.9%]) and gastrointestinal (e.g., nausea [61.2%], stomatitis [52.9%], vomiting [47.9%]), which are typical of topoisomerase I inhibitor-based ADCs and manageable with supportive care [96, 97]
GHK-Cu, BPC-157, and TB-500 are studied along different mechanistic lines: GHK-Cu for ECM and collagen signaling, BPC-157 for angiogenic and tissue-repair pathways, and TB-500 for actin regulation and cell migration